Bill Text: MN SF4058 | 2023-2024 | 93rd Legislature | Introduced
Bill Title: Commissioner of human services authorization to provide separate reimbursement for biological products provided in the inpatient hospital setting as part of cell or gene therapy to treat rare diseases
Spectrum: Slight Partisan Bill (Democrat 2-1)
Status: (Introduced - Dead) 2024-02-22 - Referred to Health and Human Services [SF4058 Detail]
Download: Minnesota-2023-SF4058-Introduced.pdf